2
Letters Response Response to Drs. Straub and Jessop Rafael Franco 1 , Rodrigo Pacheco 2 , Carmen Lluis 1 , Gerard P. Ahern 3 and Peta J. O’Connell 4 1 IDIBAPS (Institut d’Investigacions Biome ` diques August Pi I Sunyer) and Department of Biochemistry and Molecular Biology, University of Barcelona, 08028 Barcelona, Spain 2 Laboratorio de Inmunogene ´tica, Departamento de Microbiologı´a y Gene ´ tica Molecular, Facultad de Ciencias Biolo ´ gicas, Pontificia Universidad Cato ´ lica de Chile, Santiago E-8331010, Chile 3 Department of Pharmacology, Georgetown University, MedDent SW401, Washington, DC 20007, USA 4 BioTherapeutics Research Group, Robarts Research Institute, and the Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario N6A 5K8, Canada We thank Drs. Straub and Jessop for their comments and interest in our recent paper on ‘The emergence of neuro- transmitters as immune modulators’ [1]. It has long been appreciated and widely acknowledged that a variety of molecules with key functions in the neuroendocrine sys- tem, including neurotransmitters, peptides and hormones, can exert profound effects on the development and matu- ration of immune responses. The intent of our recent review, however, was to focus on a novel concept in leu- kocyte signalling, namely neurotransmission at the immune synapse. We welcome a vigorous discussion of this topic, because it is through this process that emerging paradigms are most robustly tested and further developed. The impetus for the review article arose because of recent data from our laboratories that demonstrated that dendritic cells can sequester and release neurotransmit- ters, enabling them to activate neurotransmitter receptors expressed by T cells [2,3]. The relevance of these new findings, with respect to the established works of Drs. Straub and Jessop, is evidenced for example, by the publication of contemporaneous commentaries [4]. The objective of our review was to highlight the recent findings in this rapidly progressing field and to discuss neurotransmitter signalling at the immunological synapse. Unfortunately, limitations of space meant that we could not acknowledge the contributions of all authors working in closely allied fields of neuroimmunology. Some omissions are therefore inevitable. Where possible, we cited primary articles over the past 2–4 years and referenced review articles for older contributions as is the convention for Trends reviews. We therefore apologize to Drs. Straub and Jessop and indeed any other authors whom we have not been able to cite directly, but note that their work, along with many relevant others is well represented in our chosen reviews. In 1993, Rinner and Schauenstein [5] indeed reported that lymphocytes (not specifically T lymphocytes) possess choline-acetyltransferase activity. In our article, we cited the review from Kawashima and Fujii, in Japan [6], which clearly reports earlier observations of the localization and synthesis of acetylcholine (ACh) in human T cells, as well as the report by Rinner et al. [7] that rat lymphocytes secrete acetylcholine depending on their differentiation and activation. In our opinion, the citations in our review are appropriate, as is the reference to this excellent review [6]. Our statement related to corticosteroids and catechol- amines refers to immune regulation by these compounds secreted from the adrenal gland and sympathetic nerves, respectively. We regret any confusion caused. We stated that catecholamines ‘generally’ exert an immunosuppres- sive effect. This is certainly not a categorical assertion, and we specifically added ‘Interestingly, there are exceptions to this general trend’. Indeed, the recent discovery that dopa- mine downregulates the function of regulatory T cells adds further complexity to this issue [8]. The word ‘spleen’ appears only once in our review, and we did not explicitly state that the spleen is innervated; furthermore, we are aware this remains controversial in mammals. In our review, we reported on findings that T cells synthesize and release ACh upon activation [5,6]. As stated, ‘activation [of T cells] typically occurs in the para- cortex of lymph nodes, or the periarteriolar lymphoid sheath of the spleen.’ ACh released from these activated T cells might lead to high local concentrations of ACh and autocrine/paracrine signalling via muscarinic or nicotinic ACh receptors expressed on the surface of T cells. Further- more, lymph nodes have an additional source of ACh from nerve terminals, which may also contribute to cholinergic signalling in T cells. Similarly, our review of recent findings on the role of 5-HT (serotonin) in T-cell function has also been miscon- strued by Drs. Straub and Jessop. In the original context of our review, we highlight the recent novel finding that T cells can synthesize serotonin [9] and discuss the specific receptor-mediated signalling pathways that have been definitively identified in T cells [1,9]. In our opinion, these data constitute new, relevant and direct evidence that serotonin is important for T-cell function. Drs. Straub and Jessop mention that opioid production by immune cells in the vicinity of nerve fibres can affect pain reception pathways [10]; however, the concept of volume transmission is not explicitly outlined in this paper. ‘Wiring transmission’ and ‘volume transmission’ are terms coined in 1986 by Agnati et al. to distinguish long-range (volume) from short-range (wiring) neurotrans- mission ([11], reviewed in [12]). Wiring transmission describes the neurotransmitter-induced activation of Corresponding author: Franco, R. ([email protected]). Update Trends in Immunology Vol.29 No.7 304

Response to Drs. Straub and Jessop

Embed Size (px)

Citation preview

Page 1: Response to Drs. Straub and Jessop

Update Trends in Immunology Vol.29 No.7

Letters Response

Response to Drs. Straub and Jessop

Rafael Franco1, Rodrigo Pacheco2, Carmen Lluis1, Gerard P. Ahern3 andPeta J. O’Connell4

1 IDIBAPS (Institut d’Investigacions Biomediques August Pi I Sunyer) and Department of Biochemistry and Molecular Biology,

University of Barcelona, 08028 Barcelona, Spain2 Laboratorio de Inmunogenetica, Departamento de Microbiologıa y Genetica Molecular, Facultad de Ciencias Biologicas, Pontificia

Universidad Catolica de Chile, Santiago E-8331010, Chile3 Department of Pharmacology, Georgetown University, MedDent SW401, Washington, DC 20007, USA4 BioTherapeutics Research Group, Robarts Research Institute, and the Department of Anatomy and Cell Biology, University of

Western Ontario, London, Ontario N6A 5K8, Canada

We thank Drs. Straub and Jessop for their comments andinterest in our recent paper on ‘The emergence of neuro-transmitters as immune modulators’ [1]. It has long beenappreciated and widely acknowledged that a variety ofmolecules with key functions in the neuroendocrine sys-tem, including neurotransmitters, peptides and hormones,can exert profound effects on the development and matu-ration of immune responses. The intent of our recentreview, however, was to focus on a novel concept in leu-kocyte signalling, namely neurotransmission at theimmune synapse. We welcome a vigorous discussion ofthis topic, because it is through this process that emergingparadigms are most robustly tested and further developed.

The impetus for the review article arose because ofrecent data from our laboratories that demonstrated thatdendritic cells can sequester and release neurotransmit-ters, enabling them to activate neurotransmitter receptorsexpressed by T cells [2,3]. The relevance of these newfindings, with respect to the established works ofDrs. Straub and Jessop, is evidenced for example, by thepublication of contemporaneous commentaries [4].

The objective of our review was to highlight the recentfindings in this rapidly progressing field and to discussneurotransmitter signalling at the immunological synapse.Unfortunately, limitations of spacemeant that we could notacknowledge the contributions of all authors working inclosely allied fields of neuroimmunology. Some omissionsare therefore inevitable. Where possible, we cited primaryarticles over the past 2–4 years and referenced reviewarticles for older contributions as is the convention forTrends reviews. We therefore apologize to Drs. Strauband Jessop and indeed any other authors whom we havenot been able to cite directly, but note that their work, alongwithmany relevant others is well represented in our chosenreviews.

In 1993, Rinner and Schauenstein [5] indeed reportedthat lymphocytes (not specifically T lymphocytes) possesscholine-acetyltransferase activity. In our article, we citedthe review from Kawashima and Fujii, in Japan [6], whichclearly reports earlier observations of the localization andsynthesis of acetylcholine (ACh) in human T cells, as wellas the report by Rinner et al. [7] that rat lymphocytessecrete acetylcholine depending on their differentiation

Corresponding author: Franco, R. ([email protected]).

304

and activation. In our opinion, the citations in our revieware appropriate, as is the reference to this excellent review[6].

Our statement related to corticosteroids and catechol-amines refers to immune regulation by these compoundssecreted from the adrenal gland and sympathetic nerves,respectively. We regret any confusion caused. We statedthat catecholamines ‘generally’ exert an immunosuppres-sive effect. This is certainly not a categorical assertion, andwe specifically added ‘Interestingly, there are exceptions tothis general trend’. Indeed, the recent discovery that dopa-mine downregulates the function of regulatory T cells addsfurther complexity to this issue [8].

The word ‘spleen’ appears only once in our review, andwe did not explicitly state that the spleen is innervated;furthermore, we are aware this remains controversial inmammals. In our review, we reported on findings that Tcells synthesize and release ACh upon activation [5,6]. Asstated, ‘activation [of T cells] typically occurs in the para-cortex of lymph nodes, or the periarteriolar lymphoidsheath of the spleen.’ ACh released from these activatedT cells might lead to high local concentrations of ACh andautocrine/paracrine signalling via muscarinic or nicotinicACh receptors expressed on the surface of T cells. Further-more, lymph nodes have an additional source of ACh fromnerve terminals, which may also contribute to cholinergicsignalling in T cells.

Similarly, our review of recent findings on the role of5-HT (serotonin) in T-cell function has also been miscon-strued by Drs. Straub and Jessop. In the original context ofour review, we highlight the recent novel finding thatT cells can synthesize serotonin [9] and discuss the specificreceptor-mediated signalling pathways that have beendefinitively identified in T cells [1,9]. In our opinion, thesedata constitute new, relevant and direct evidence thatserotonin is important for T-cell function.

Drs. Straub and Jessop mention that opioid productionby immune cells in the vicinity of nerve fibres can affectpain reception pathways [10]; however, the concept ofvolume transmission is not explicitly outlined in thispaper. ‘Wiring transmission’ and ‘volume transmission’are terms coined in 1986 by Agnati et al. to distinguishlong-range (volume) from short-range (wiring) neurotrans-mission ([11], reviewed in [12]). Wiring transmissiondescribes the neurotransmitter-induced activation of

Page 2: Response to Drs. Straub and Jessop

Update Trends in Immunology Vol.29 No.7

nearby synaptic receptors. By contrast, volume trans-mission describes the ‘spillover’ activation of extrasynapticreceptors. We used these terms to illustrate that similarmechanisms can occur in both the nervous and immunesystems. For neuroimmunologists, we feel that these arehelpful and interesting analogies to make.

As evidenced in our review, the topic of neurotransmit-ter synthesis and signalling in the immune system is arapidly developing field of neuroimmunology. This discus-sion is proof that there is a real vitality and excitement inthe field, and we appreciate the continuing debate.

References1 Franco, R. et al. (2007) The emergence of neurotransmitters as immune

regulators. Trends Immunol. 28, 400–4072 O’Connell, P.J. et al. (2006) A novel form of immune signaling revealed

by transmission of the inflammatory mediator serotonin betweendendritic cells and T cells. Blood 107, 1010–1017

3 Pacheco, R. et al. (2006) Glutamate released by dendritic cells as a novelmodulator of T cell activation. J. Immunol. 177, 6695–6704

4 Gordon, J. and Barnes, N.M. (2007) Serotonin: a real blast for T cells.Blood 109, 3130–3131

5 Rinner, I. and Schauenstein, K. (1993) Detection of choline-acetyltranferase in lymphocytes. J. Neurosci. Res. 35, 188–191

2nd Mediterranean Clinica

October 4–

Papillon Ayscha Hotel,

INTERNATIONAL ORGAGunnur Deniz (Istanbul, Turkey) � Ha

Moncef Zouali (Paris, France) � L

Margarida CARNEIRO

TOPICImaging and signalling in

Tolerance and a

Autoimmunity and

Transplan

Infections and vacci

Asthma and

Cance

Immunodef

Novel targets in clin

CONTACT INFO

Scientific SecretariatHaluk Barbaros Oral, MD, PhD

E-mail: [email protected]

www.clinicalimmu

6 Kawashima, K. and Fujii, T. (2003) The lymphocytic cholinergic systemand its biological function. Life Sci. 72, 2101–2109

7 Rinner, I. et al. (1998) Rat lymphocytes produce and secreteacetylcholine in dependence of differentiation and activation.J. Neuroimmunol. 81, 31–37

8 Cosentino, M. et al. (2007) Human CD4+CD25+ regulatory T cellsselectively express tyrosine hydroxylase and contain endogenouscatecholamines subserving an autocrine-paracrine inhibitoryfunctional loop. Blood 109, 632–642

9 Leon-Ponte, M. et al. (2007) Serotonin provides an accessory signal toenhance T-cell activation by signaling through the 5-HT7 receptor.Blood109, 3139–3146

10 Stein, C. et al. (1990) Opioids from immunocytes interact withreceptors on sensory nerves to inhibit nociception in inflammation.Proc. Natl. Acad. Sci. U. S. A. 87, 5935–5939

11 Agnati, L.F. et al. (1986) A correlation analysis of the regional distri-bution of central enkephalin and beta-endorphin immunoreactiveterminals and of opiate receptors in adult and old male rats. Evidencefor the existence of two main types of communication in the centralnervous system: the volume transmission and the wiring transmission.Acta Physiol. Scand. 128, 201–207

12 Zoli, M. et al. (1999) Volume transmission in the CNS and its relevancefor neuropsychopharmacology. Trends Pharmacol. Sci. 20, 142–150

1471-4906/$ – see front matter � 2008 Elsevier Ltd. All rights reserved.

doi:10.1016/j.it.2008.04.003 Available online 2 June 2008

l Immunology Meeting

7, 2008

Antalya – TURKEY

NISING COMMITTEEluk Barbaros Oral (Bursa, Turkey)

uciano Adorini (Milan, Italy)

(Oeiras, Portugal)

Sthe immune system

utoimmunity

inflammation

tation

ne development

allergy

r

iciencies

ical immunology

RMATION

Congress SecretariatSerenas Tourism Congress &

Organizational Services

E-mail: [email protected]

nology2008.org

305